Regencell Bioscience (RGC)

• Market cap: $65.1M
• 1 day: 3.73%
• 5 days: 0.20%
• 1 month: 4.82%
• 3 months: 0.00%
• 6 months: 48.37%
• Year to date: 3.73%
• 1 year: -38.73%
• 5 years: -52.38%
• 10 years: -52.38%

About: Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.

Employees: 12

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

5,209% more capital invested

Capital invested by funds: $1.89K [Q2] → $100K (+$98.6K) [Q3]

0.13% more ownership

Funds ownership: 0% [Q2] → 0.14% (+0.13%) [Q3]

0% more first-time investments, than exits

New positions opened: 1 | Existing positions closed: 1

33% less funds holding

Funds holding: 3 [Q2] → 2 (-1) [Q3]